Tuberculosis and Respiratory Diseases

Scope & Guideline

Uncovering breakthroughs in tuberculosis research.

Introduction

Welcome to the Tuberculosis and Respiratory Diseases information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Tuberculosis and Respiratory Diseases, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1738-3536
PublisherTHE KOREAN ACAD TUBERCULOSIS & RESPIRATORY DISEASES
Support Open AccessYes
CountrySouth Korea
TypeJournal
Convergefrom 1980 to 2024
AbbreviationTUBERC RESPIR DIS / TUBERC. RESP. DIS.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address101-605, 58, Banpo-daero, Seocho-gu, SEOUL 06652, SOUTH KOREA

Aims and Scopes

The journal 'Tuberculosis and Respiratory Diseases' primarily focuses on advancing research and knowledge surrounding respiratory diseases, particularly tuberculosis and chronic obstructive pulmonary disease (COPD). It aims to publish high-quality research that enhances the understanding, diagnosis, treatment, and management of these conditions.
  1. Tuberculosis Research:
    The journal emphasizes studies related to tuberculosis, including epidemiology, treatment strategies, and the development of novel diagnostic methods, aiming to improve patient outcomes and public health responses.
  2. Chronic Obstructive Pulmonary Disease (COPD):
    Research on COPD is a core focus, covering various aspects such as pathophysiology, management strategies, exacerbation definitions, and the impact of comorbidities on patient health.
  3. Lung Cancer and Respiratory Neoplasms:
    The journal includes significant research on lung cancers, particularly non-small cell lung cancer, exploring treatment advancements, biomarkers for prognosis, and patient management.
  4. Infectious Respiratory Diseases:
    In addition to tuberculosis, the journal addresses other infectious respiratory diseases, including studies on viral infections like COVID-19, their clinical outcomes, and the impact on patients with pre-existing respiratory conditions.
  5. Pulmonary Rehabilitation and Patient Quality of Life:
    The journal publishes research on rehabilitation programs and interventions aimed at improving the quality of life for patients with chronic respiratory diseases, integrating psychological and social aspects.
  6. Environmental and Lifestyle Factors:
    Research on the effects of environmental factors, such as air pollution and smoking, on respiratory health is highlighted, recognizing their role in exacerbating conditions like COPD and asthma.
The journal has been actively adapting to new challenges and innovations in the field of respiratory diseases, leading to emerging themes that are gaining prominence. This section outlines these trending areas of focus.
  1. Impact of Digital Health Technologies:
    Recent publications highlight the integration of digital health solutions, such as telemedicine and mobile health applications, to improve medication adherence and patient management in respiratory diseases.
  2. Long-COVID and Post-Acute Sequelae:
    Research exploring the long-term effects of COVID-19 on respiratory health, including complications and management strategies, is increasingly significant, reflecting ongoing concerns about the pandemic's impact.
  3. Biomarkers and Personalized Medicine:
    There is a growing interest in identifying biomarkers for predicting disease progression and treatment response in tuberculosis and lung cancer, paving the way for personalized treatment approaches.
  4. Rehabilitation and Quality of Life Initiatives:
    Studies focusing on the rehabilitation of patients with chronic respiratory diseases and their quality of life are on the rise, emphasizing the holistic management of these conditions.
  5. Environmental Health and Respiratory Disease Interactions:
    Research on the interplay between environmental factors, such as air pollution, and respiratory diseases is becoming more prevalent, underscoring public health implications.

Declining or Waning

While certain themes remain prominent, others are showing signs of declining interest or fewer publications in recent years. This section identifies those waning scopes within the journal's focus.
  1. Traditional Tuberculosis Epidemiology Studies:
    There appears to be a shift away from basic epidemiological studies of tuberculosis towards more innovative research focusing on treatment and management strategies, as well as integration of technology.
  2. General Asthma Research:
    While asthma remains a topic of interest, the publication of studies focused solely on asthma without connections to COPD or other comorbidities is decreasing, indicating a trend towards integrated respiratory disease research.
  3. Historical Perspectives on Respiratory Diseases:
    Research that primarily revisits historical data or long-standing paradigms without introducing new insights or advancements is less frequently published, suggesting a preference for contemporary and innovative research.
  4. Pharmacological Studies on Older Medications:
    There is a noticeable decline in research focused on older medications for respiratory diseases, as the journal increasingly prioritizes studies on newer therapeutic options and combination therapies.

Similar Journals

Lancet Respiratory Medicine

Exploring new horizons in respiratory medicine.
Publisher: ELSEVIER SCI LTDISSN: 2213-2600Frequency: 12 issues/year

The Lancet Respiratory Medicine, published by Elsevier in the United Kingdom, is a premier journal dedicated to the field of pulmonary and respiratory medicine. With its impressive impact factor and a prestigious ranking of #1 out of 155 in its category as of 2023, it holds a remarkable position in advancing research and clinical practices in respiratory health. The journal invites original research, reviews, and clinical studies that aim to propel the understanding of respiratory diseases, fostering innovations in treatment and management strategies. Operating under a Q1 category in Scopus rankings, it is an essential platform for researchers, healthcare professionals, and students who are committed to enhancing patient care and advancing knowledge in this crucial area of medicine. The Lancet Respiratory Medicine remains a vital resource for the latest findings and discussions shaping the future of respiratory health.

Pulmonary Medicine

Fostering Collaboration for a Healthier Tomorrow
Publisher: HINDAWI LTDISSN: 2090-1836Frequency: 1 issue/year

Pulmonary Medicine, published by HINDAWI LTD, stands as a prestigious open-access journal since 2010, dedicated to advancing the field of pulmonary and respiratory medicine. Located in Egypt, this journal is indexed with an ISSN of 2090-1836 and an E-ISSN of 2090-1844, and it has attained a commendable Q2 ranking in both the miscellaneous medicine and pulmonary health categories, indicative of its significant impact and quality. With an impressive Scopus ranking of #15 out of 155 in the pulmonary and respiratory medicine category, the journal is positioned in the 90th percentile, highlighting its relevance and contribution to ongoing research. The journal aims to publish high-quality original research, reviews, and clinical studies that address pressing issues in pulmonary health, making it a vital resource for researchers, clinicians, and students seeking to enhance their understanding and practice in respiratory medicine. By embracing an open-access model, Pulmonary Medicine provides a platform for disseminating knowledge, fostering collaboration, and driving innovation within the global scientific community.

Respiratory Medicine and Research

Exploring breakthroughs in respiratory research.
Publisher: ELSEVIERISSN: Frequency: 2 issues/year

Respiratory Medicine and Research, published by Elsevier, is a pivotal journal in the field of Pulmonary and Respiratory Medicine, dedicated to advancing the understanding and treatment of respiratory diseases. Since its inception in 2019, the journal has provided a platform for high-quality research, contributing significantly to the scientific community's knowledge base, as reflected in its impressive Q2 categorization in 2023. With a Scopus rank of #94 out of 155, placing it in the 39th percentile, this journal is essential for researchers, professionals, and students seeking the latest advancements in respiratory medicine. Although currently categorized as a non-open access publication, it remains accessible to those affiliated with institutions with subscriptions. Published in France, the journal aims to foster collaboration and innovation by highlighting original research, clinical studies, and comprehensive reviews that address pressing issues in respiratory health.

Zeitschrift fur Pneumologie

Unlocking New Perspectives in Lung Diseases
Publisher: SPRINGER HEIDELBERGISSN: 2731-7404Frequency: 6 issues/year

Zeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.

Multidisciplinary Respiratory Medicine

Unlocking the potential of respiratory research for global impact.
Publisher: MATTIOLI 1885ISSN: 1828-695XFrequency: 1 issue/year

Multidisciplinary Respiratory Medicine is a leading open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by MATTIOLI 1885, this journal has been serving the academic community since 2008 and has become a vital platform for the dissemination of research and clinical insights in this critical area of healthcare. With an impressive impact factor placing it in the Q2 category of pulmonary medicine in 2023 and a Scopus rank of #67 out of 155, it reflects a solid commitment to high-quality research. The journal provides researchers, health professionals, and students with accessible and updated information, fostering collaboration and advancement in respiratory health. Operating from the United Kingdom, it has embraced open access since 2010, ensuring that all articles are freely available, thus maximizing the reach and impact of its scholarly contributions. Whether you are looking to publish innovative findings or gain insights from industry leaders, Multidisciplinary Respiratory Medicine is your go-to resource for the latest in respiratory science.

Annals of Thoracic Medicine

Delivering impactful findings for respiratory and cardiac health.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1817-1737Frequency: 4 issues/year

Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.

Lung India

Catalyzing change in pulmonary practices worldwide.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.

RESPIRATORY MEDICINE

Pioneering Research for Better Breathing
Publisher: W B SAUNDERS CO LTDISSN: 0954-6111Frequency: 12 issues/year

Respiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.

Breathe

Transforming respiratory care through scholarly discourse.
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 1810-6838Frequency: 4 issues/year

Breathe, published by the European Respiratory Society Journals Ltd, is a prominent open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. With an ISSN of 1810-6838 and an E-ISSN of 2073-4735, this journal has been contributing to scholarly discourse since 2008. Nestled in the United Kingdom, it serves as a vital platform for researchers, clinicians, and educators, particularly in the areas of respiratory pathophysiology, diagnostic methods, and therapeutic interventions. Currently classified in the third quartile (Q3) for pulmonary and respiratory medicine, Breathe ranks 91st out of 155 in Scopus, reflecting its growing influence in the discipline. The journal aims to publish high-quality, peer-reviewed research that fosters collaboration and innovation in lung health, making significant strides toward improving patient outcomes. Whether you are a seasoned professional or an up-and-coming researcher, Breathe offers a wealth of knowledge and resources to support your work in this crucial area of medicine.

Minerva Respiratory Medicine

Connecting research and practice in pulmonary health.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2784-8477Frequency: 4 issues/year

Minerva Respiratory Medicine is a prominent academic journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by EDIZIONI MINERVA MEDICA in Italy, this journal provides a vital platform for the dissemination of innovative research, clinical studies, and review articles that address the complexities of respiratory health. With an ISSN of 2784-8477 and an E-ISSN of 2724-6493, it serves as an open-access resource, allowing researchers, healthcare professionals, and students access to invaluable information without barriers. The journal is categorized in the fourth quartile of the 2023 rankings in the field of pulmonary and respiratory medicine, indicating its emerging role in the academic landscape. Despite its nascent status—converging from 2021 to 2024—Minerva Respiratory Medicine is committed to enhancing knowledge and practice in respiratory care, focusing on both innovative therapies and traditional approaches. With its aim to foster collaboration and communication among professionals in the field, this journal is an essential resource for those passionate about improving respiratory health outcomes.